Use of Sugammadex for Reversal of Paralysis in Microlaryngoscopy

Trial Profile

Use of Sugammadex for Reversal of Paralysis in Microlaryngoscopy

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 May 2017

At a glance

  • Drugs Glycopyrrolate (Primary) ; Neostigmine (Primary) ; Sugammadex (Primary) ; Remifentanil; Rocuronium bromide; Sevoflurane
  • Indications Neuromuscular blockade
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 May 2017 Status changed from not yet recruiting to recruiting.
    • 17 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top